Balchem acquires vitamin K2 specialist Kappa Bioscience eyeing EU market

Related Articles

FormattedPicture

BUSINESS NEWS

This week in nutrition news, Balchem completed its acquisition of Kappa Bioscience for a value of NOK 3.175 billion (US$338 million). Lallemand Health Solutions... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Kappa Bioscience’s nature-identical vitamin K2 – K2Vital – is provided as a Reference Standard for the United States Pharmacopeia. This means the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

PLT Health Solutions will be marketing vitamin K2 (MK-7) manufactured by Japan-based J-Oil Mills, in North America. The move aims to expand the vitamin K2 market across... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

French mills are diversifying from their staple white and rustic breads to incorporate more health-oriented flour blends. Higher protein and fiber content with chickpeas... Read More

FormattedPicture

FOOD RESEARCH

New research is helping Gnosis by Lesaffre position its MenaQ7 “vitamin K2 as MK-7” for healthy aging and active nutrition. Shown to counter induce oxidative... Read More

trans